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entre for Public Health (CPH), National Institute for Health and Care Excellence (NICE), London, United KingdomPublic health activities can contribute to the reduction of per-
istent health inequalities that exist both between and within
ountries.1 At a global level, there is political commitment to
upport such activities, evidenced by World Health Organisation
WHO) Member States signing up to the sixty ﬁfth World Health
ssembly resolution Reducing health inequities through action on the
ocial determinants of health.2 Many countries, including England
nd Spain have followed through to identify the most effective
ontext speciﬁc actions required to bring about fair and equal
pportunities for health.3,4 However, publishing such reports is not
ufﬁcient to achieve equity goals, without the necessary willingness
nd capacity to act.
The Centre for Public Health (CPH) at the National Institute
or Health and Care Excellence (NICE) aims to contribute to the
mplementation of such actions through the production of evidence
ased guidance. CPH provides national guidance on the promotion
f good health for those working in the NHS, local authorities and
he wider public and voluntary sector. It makes recommendations
or England on what is known from research and practice about the
ffectiveness and cost effectiveness of interventions and broader
rogrammes.
So what beneﬁts does the NICE public health approach hold and
hat are the challenges?
The most obvious beneﬁt is the robust processes and methods
hich have secured NICE’s reputation as one of the most produc-
ive and best organized developers of guidance in the world.5,6
ogether they ensure that guidance is: based on a rigorous assess-
ent of the evidence; developed by independent committees;
egularly informed by the public, patients, and service users;
uided by potential implementers of it; and subjected to ongoing
onsultation with stakeholders to ensure its rigour and appropri-
teness. In professional circles at least the guidance is trusted.7
he credibility of the organisation has grown through a commit-
ent and willingness to undergo ongoing public scrutiny of its
ork.8
More speciﬁcally for public health, CPH ensures its guidance is
ligned with a strong public health approach. This is illustrated in
 number of ways.
First, it is set within the context of a social determinants andealth inequalities approach to population health. Guidance devel-
pment is supported by a conceptual framework9,10 that ensures
he multiple layers of inﬂuence on health are accounted for.
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ttp://dx.doi.org/10.1016/j.gaceta.2013.04.008This framework describes four vectors –population, environment,
society and organisations – which are used to articulate the mech-
anisms of cause and interventions. They highlight how guidance
might be developed to alleviate differences in health experience
at population and sub-population levels. Guidance developed to
reduce harm from the misuse of alcohol provides an example
of its use in practice.11 A range of recommendations were made
including: minimum pricing on alcohol (population level); restric-
tions on advertising (industry focussed) and locally based brief
interventions by primary care and other professionals. The pur-
pose of the guidance was to uphold a basic principle of public
health. That is, to promote a range of interventions that can act
synergistically to bring about multiple health and often social
beneﬁts.
Secondly, CPH strives for methodological diversity, which Bon-
nefoy et al.12 argue is essential for building an evidence base
for action on the social determinants of health. Evidence is not
appraised on the basis of adherence to a single evidence hierarchy
where a particular method (or design) is given priority. Instead, it
is assessed on whether the research method used is appropriate
for the question being asked (and the decision needing to be made)
and the extent to which its own methodological principles are well
executed.13 This approach compensates for the fact that evidence
derived from a single source, rarely provides simple answers of
what to do. For example, CPH guidance Hepatitis B and C – ways
to promote and offer testing employed both quantitative and qual-
itative research to help produce it.14 The former highlights what
works in general. The latter describes how the barriers to acces-
sing available services can be overcome for those most at risk of
infection. Taking a mixed method approach to the collection and
synthesis of evidence ensures that public health guidance is based
on a better understanding of how interventions might be applied
effectively in real life.11,15 Given the complexity of solutions to
most public health issues and that evidence only provides the start-
ing point for a set of plausible actions, methodological pluralism is
essential to ensure guidance is ﬁt for purpose.11,16
Assessing value for money is a core function of NICE. It is an
opportunity to present the economic case for public health and as
such provides a third beneﬁt. Despite a paucity of public health eco-
nomic studies and the methodological difﬁculties associated with
assessing interventions,17,18 NICE methods allow estimates of cost
effectiveness to be made based on extrapolations of effectiveness
data.
All published recommendations for action are deemed to be cost
effective. Owen et al.19 found that overall the public health inter-
ventions assessed by CPH, as judged against the NICE threshold20
ts reserved.
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re good value for money and cheap. Economic appraisal work
as been further developed to include the ‘return on investment’
ROI) initiative. Using tobacco control as an example, it has devel-
ped a tool to support local decision-making and prioritisation.
t examines a portfolio of tobacco control interventions using
ocal data to assess the economic returns that can be expected
y them individually or in combination in the short to long
erm.21
Of course, the beneﬁts described above are my  personal choice
nd as an employee of NICE might be subject to bias. The reader can
eview the most recent editions of the CPH process and methods
anuals to decide for themselves whether the NICE public health
pproach has relevance for the Spanish context.22
NICE guidance can make a contribution to health goals but chal-
enges exist to ensure its advice is followed.
Public health guidance is not mandatory! Whilst the organisa-
ion has an obligation to make certain that its guidance is robust
nd credible, expressed appropriately, and disseminated in ways
hat encourage the widest possible use,23 its implementation is
ubject to the enthusiasm of professionals. Given the wide range
f professionals required to bring about public health goals, this is
 challenge. In the health service, some staff are employed directly
o implement NICE guidance. However, the responsibility for pub-
ic health in England is now with local government. Evidence based
ulture in this setting is not so well known, used or even accepted.
 general lesson for guidance producers is to ensure they pay atten-
ion to the needs of those who are in a position to implement it. The
ext big task for CPH is to make its work relevant for local govern-
ent. The potential of the ROI initiative to highlight ﬁnancial gains
ecomes paramount in this scenario.
As yet there have been no formal evaluations of the uptake
f CPH guidance, nor the impact it might have had on any
articular outcome –perhaps the latter is too tall an order? How-
ver, the implementation programme at NICE produces a range
f tools and resources to support local activities and collects
xamples of practice that highlight how guidance has supported
ractice.
To reiterate, neither the production of evidence alone, nor guid-
nce produced as a result of it will have an impact on health goals
nless an imperative for action exists and the public health work-
orce is ready to act. With regards to the latter, CPH guidance often
ncludes recommendations which make explicit the necessary
onditions for success (i.e., for interventions to be implemented
ffectively). Such conditions usually operate at a systems level.
or example, guidance developed to improve the ways in which
ommunities are involved in the health development process24
ncluded a set of pre-requisites which were seen as essential for
ommunity based approaches to work. Pre-requisites included:
ong term investment commitment; organisational and cultural
hange; and sharing of power between communities and statutory
gencies.
Where political readiness is required, the implementation of
ecommendations can be a little more difﬁcult. The introduction
f a minimum price for alcohol as recommended by guidance in
010 has yet to be achieved. The role of NICE is not to tell the gov-
rnment what to do but to present authoritative recommendations
ased on robust analysis of the evidence. Evidence for macro level
nterventions in this case is strong, some suggesting25 their impact
n population health has more potential than any locally based
ntervention. Those working in public health will be familiar with
he role of sustained advocacy to complete the ‘evidence jigsaw’
hen policy change is not forthcoming.16Disinvestment in public health is always a possibility given the
ften long-term nature of its beneﬁts, but this becomes more acute
n times of austerity and public sector cuts. Sustaining and advanc-
ng, the science and art of evidence based public health in this
213;27(4):287–289
context becomes ever more critical. The capability of NICE methods
and processes provide a good starting point for this task.
Is learning from NICE transferable? Of course it is, but context
matters. The success of NICE has depended as much on the pro-
cess by which its guidance is produced as the science upon which
it is based. For public health, this by necessity involves context
speciﬁc; assessments of population health goals; an understand-
ing of how best to conﬁgure local systems and circumstances for
effective implementation; and perhaps most importantly identiﬁ-
cation, commitment and engagement of all those actors who have
an opportunity to create the optimum conditions for health.
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